They were either given weekly exenatide injections or a placebo jab. At the end of the 96-week study those taking exenatide, ...

AstraZeneca Plc's AZN Bydureon BCise (exenatide 2 mg prolonged-release suspension for injection) is indicated for type-2 diabetes. Novo Nordisk A/S' NVO semaglutide is approved as Ozempic and ...

Now, researchers at Thomas Jefferson University have found that combining two other diabetes drugs—dapagliflozin and ...

Reduced frequency is very encouraging for patient compliance and could help those who dislike weekly injections and ...

Our study demonstrates reduction in postprandial glucose after exenatide injection in adolescents with type 1 diabetes. These effects were associated with delayed gastric emptying, and the results ...

n=8), weekly exenatide injections (Bydureon BCise®, n=8), or weekly 1 mg semaglutide injections (Wegovy®, n=8) for a 9-week treatment duration. Changes in weight will be measured. The study is ...

n=8), weekly exenatide injections (Bydureon BCise®, n=8), or weekly 1 mg semaglutide injections (Wegovy®, n=8) for a 9-week treatment duration. Changes in weight will be measured. The study is ...

It is unclear whether the increased efficacy stems entirely from eliminating the dosing errors that took place when exenatide was tested as an injection or whether other factors, such as ...